Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 

Publications

Showing records 1 - 20 (of 53)

Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)

ID Author Year Title Publisher
4378930  Probstel, A. K.; Kuhle, J.; Lecourt, A. C.; Vock, I.; Sanderson, N. S.; Kappos, L.; Derfuss, T. 2016 Multiple Sclerosis and Antibodies against KIR4.1 N Engl J Med
4378927  Rust, H.; Kuhle, J.; Kappos, L.; Derfuss, T. 2016 Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy Neurology: Neuroimmunology & Neuroinflammation
4378928  Rasenack, M.; Rychen, J.; Andelova, M.; Naegelin, Y.; Stippich, C.; Kappos, L.; Lindberg, R. L.; Sprenger, T.; Derfuss, T. 2016 Efficacy and Safety of Fingolimod in an Unselected Patient Population PLoS One
4378939  Derfuss, T.; Ontaneda, D.; Nicholas, J.; Meng, X.; Hawker, K. 2016 Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials Multiple Sclerosis and Related Disorders
4378935  Havla, J.; Warnke, C.; Derfuss, T.; Kappos, L.; Hartung, H. P.; Hohlfeld, R. 2016 Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis Deutsches Ärzteblatt international
4378933  Kuhle, J.; Barro, C.; Andreasson, U.; Derfuss, T.; Lindberg, R.; Sandelius, A.; Liman, V.; Norgren, N.; Blennow, K.; Zetterberg, H. 2016 Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa Clinical Chemistry and Laboratory Medicine
4378934  Kappos, L.; Arnold, D. L.; Bar-Or, A.; Camm, J.; Derfuss, T.; Kieseier, B. C.; Sprenger, T.; Greenough, K.; Ni, P.; Harada, T. 2016 Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial The Lancet Neurology
4378932  Kuhle, Jens; Barro, Christian; Disanto, Giulio; Mathias, Amandine; Soneson, Charlotte; Bonnier, Guillaume; Yaldizli, Ozgür; Regeniter, Axel; Derfuss, Tobias; Canales, Mathieu; Schluep, Myriam; Du Pasquier, Renaud A.; Krueger, Gunnar; Granziera, Cristina 2016 Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity Multiple Sclerosis Journal
4378931  Meira, Maria; Sievers, Claudia; Hoffmann, Francine; Haghikia, Aiden; Rasenack, Maria; Decard, Bernhard F.; Kuhle, Jens; Derfuss, Tobias; Kappos, Ludwig; Lindberg, Raija L.P. 2016 Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development Neurol Neuroimmunol Neuroinflamm
4378940  Decard, B. F.; Derfuss, T. 2016 Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future Seminars in Neurology
4378936  Disanto, G.; Benkert, P.; Lorscheider, J.; Mueller, S.; Vehoff, J.; Zecca, C.; Ramseier, S.; Achtnichts, L.; Findling, O.; Nedeltchev, K.; Radue, E. W.; Sprenger, T.; Stippich, C.; Derfuss, T.; Louvion, J. F.; Kamm, C. P.; Mattle, H. P.; Lotter, C.; Du Pasquier, R.; Schluep, M.; Pot, C.; Lalive, P. H.; Yaldizli, O.; Gobbi, C.; Kappos, L.; Kuhle, J.; Smsc Scientific Board, 2016 The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options PLoS One
4378938  Diebold, M.; Derfuss, T. 2016 Immunological treatment of multiple sclerosis Seminars in Hematology
4378946  Giovannoni, G.; de Jong, B.; Derfuss, T.; Izquierdo, G.; Mazibrada, G.; Molyneux, P.; Nicholas, R.; Overell, J.; Ziemssen, T.; Juliusson, G. 2015 A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe Multiple Sclerosis and Related Disorders
4378944  Kuhle, J.; Disanto, G.; Dobson, R.; Adiutori, R.; Bianchi, L.; Topping, J.; Bestwick, J. P.; Meier, U. C.; Marta, M.; Dalla Costa, G.; Runia, T.; Evdoshenko, E.; Lazareva, N.; Thouvenot, E.; Iaffaldano, P.; Direnzo, V.; Khademi, M.; Piehl, F.; Comabella, M.; Sombekke, M.; Killestein, J.; Hegen, H.; Rauch, S.; D'Alfonso, S.; Alvarez-Cermeno, J. C.; Kleinova, P.; Horakova, D.; Roesler, R.; Lauda, F.; Llufriu, S.; Avsar, T.; Uygunoglu, U.; Altintas, A.; Saip, S.; Menge, T.; Rajda, C.; Bergamaschi, R.; Moll, N.; Khalil, M.; Marignier, R.; Dujmovic, I.; Larsson, H.; Malmestrom, C.; Scarpini, E.; Fenoglio, C.; Wergeland, S.; Laroni, A.; Annibali, V.; Romano, S.; Martinez, A. D.; Carra, A.; Salvetti, M.; Uccelli, A.; Torkildsen, O.; Myhr, K. M.; Galimberti, D.; Rejdak, K.; Lycke, J.; Frederiksen, J. L.; Drulovic, J.; Confavreux, C.; Brassat, D.; Enzinger, C.; Fuchs, S.; Bosca, I.; Pelletier, J.; Picard, C.; Colombo, E.; Franciotta, D.; Derfuss, T.; Lindberg, R.; Yaldizli, O.; Vecsei, L.; Kieseier, B. C.; Hartung, H. P.; Villoslada, P.; Siva, A.; Saiz, A.; Tumani, H.; Havrdova, E.; Villar, L. M.; Leone, M.; Barizzone, N.; Deisenhammer, F.; Teunissen, C.; Montalban, X.; Tintore, M.; Olsson, T.; Trojano, M.; Lehmann, S.; Castelnovo, G.; Lapin, S.; Hintzen, R.; Kappos, L.; Furlan, R.; Martinelli, V.; Comi, G.; Ramagopalan, S. V.; Giovannoni, G. 2015 Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study Multiple Sclerosis Journal
4378948  Derfuss, T.; Curtin, F.; Guebelin, C.; Bridel, C.; Rasenack, M.; Matthey, A.; Du Pasquier, R.; Schluep, M.; Desmeules, J.; Lang, A. B.; Perron, H.; Faucard, R.; Porchet, H.; Hartung, H. P.; Kappos, L.; Lalive, P. H. 2015 A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients Multiple Sclerosis Journal
4378942  Wuhrer, Manfred; Selman, Maurice H.; McDonnell, Liam A.; Kumpfel, Tania; Derfuss, Tobias; Khademi, Mohsen; Olsson, Tomas; Hohlfeld, Reinhard; Meinl, Edgar; Krumbholz, Markus 2015 Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid Journal of Neuroinflammation
4378941  Zimmer, Andrea; Blauer, Cornelia; Coslovsky, Michael; Kappos, Ludwig; Derfuss, Tobias 2015 Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction Multiple Sclerosis and Related Disorders
3004989  Pröbstel, Anne-Katrin; Rudolf, Gabrielle; Dornmair, Klaus; Collongues, Nicolas; Chanson, Jean-Baptiste; Sanderson, Nicholas S R; Lindberg, Raija L P; Kappos, Ludwig; de Seze, Jérôme; Derfuss, Tobias 2015 Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype Journal of neuroinflammation
4378947  Derfuss, T.; Curtin, F.; Guebelin, C.; Bridel, C.; Rasenack, M.; Matthey, A.; Du Pasquier, R.; Schluep, M.; Desmeules, J.; Lang, A. B.; Perron, H.; Faucard, R.; Porchet, H.; Hartung, H. P.; Kappos, L.; Lalive, P. H. 2015 A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up Journal of Neuroimmunology
4378949  Derfuss, T.; Bergvall, N. K.; Sfikas, N.; Tomic, D. L. 2015 Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis Current Medical Research and Opinion
Showing records 1 - 20 (of 53)


MCSS v5.8 PRO. 0.013 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
07/05/2024